Sun Pharma to Acquire Organon for $11.75 Billion, Expanding Global Footprint
Sun Pharmaceutical Industries Ltd is set to acquire US-based Organon & Co for a staggering $11.75 billion, a strategic move poised to significantly expand its global footprint and elevate its standing among the world’s top pharmaceutical companies. Photograph: Francis Mascarenhas/Reuters